Dacemazine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dacemazine
Dacemazine.png
Systematic (IUPAC) name
2-dimethylamino-1-phenothiazin-10-ylethanone
Clinical data
Legal status
?
Identifiers
CAS number 518-61-6 N
ATC code None
PubChem CID 68846
ChemSpider 62079 YesY
UNII verifiedrevid = 460112476 88D34UY0QI verifiedrevid = 460112476 N
ChEMBL CHEMBL2107547 N
Chemical data
Formula C16H16N2OS 
Molecular mass 284.376 g/mol
 N (what is this?)

Dacemazine (INN, also known as Ahistan and Histantine)[1] is a phenothiazine derivative which acts as an histamine antagonist at the H1 subtype. First described in 1951, it was never marketed as a drug on its own, although a combination of dacemazine and di-tert-butylnaphthalenesulfonate was sold as an antispasmodic and antitussive under the trade name Codopectyl.[1] It was also assessed as a possible anticancer drug.[2]

References[edit]

  1. ^ a b David J. Triggle; C. R. Ganellin; F. MacDonald (1996). Dictionary of Pharmacological Agents 1. Boca Raton: Chapman & Hall/CRC. pp. p. 711. ISBN 0-412-46630-9.  Retrieved on August 2, 2008 through Google Book Search.
  2. ^ Karolyhazy G, Havas I, Jansco G, Kapas L, Sellei C. The anticarcinogenic effect of dimethylaminoacetyl-phentiazide (ahistan). Kiserletes Orvostudomany. 1952 Aug;4(4):260-2. PMID 13023855